MedPath

Automated Diagnostic Performance of Smartwatch ECG for Arrhythmia Detection Using the PulseAI Neural Network.

Recruiting
Conditions
Arrhythmias, Cardiac
Registration Number
NCT05668377
Lead Sponsor
PulseAI Ltd
Brief Summary

The study is to evaluate the performance of the PulseAI neural network technology at interpreting ECG data recorded using a single-lead Smartwatch (Apple Watch).

Detailed Description

Under subject consent, subjects will have a 12-lead ECG immediately followed by a smartwatch ECG. The heart rhythm and ECG interval measurements will be compared between the 12-lead ECG and smartwatch ECG.

The arrhythmias will include:

* Atrial Fibrillation/Flutter

* Tachycardia

* Bradycardia

* Premature Atrial Contractions

* Premature Ventricular Contractions

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patient aged 22 or older, able and willing to participate in the study
  • Patient admitted to hospital for ablation, cardioversion, or cardiac electrophysiological exploration.
  • Patient who has read the information note and has given their consent before any procedure related to the study.
Exclusion Criteria
  • Patient with a pacemaker, implantable defibrillator or cardiac resynchronisation therapy device.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate the performance of arrhythmia detection.12 months

Evaluate the performance of arrhythmia detection by the PulseAI neural network applied to ECG data collected via the Smartwatch compared to physicians' interpretation of the 12-lead ECG.

Secondary Outcome Measures
NameTimeMethod
Evaluate the performance of the Apple Watch ECG interpretation Software compared to the PulseAI software12 months

Evaluate the performance of the Apple Watch ECG interpretation Software compared to the PulseAI neural network

Evalaute the performance of QTc interval measurement12 months

Evaluate the performance of QTc interval measurement by the PulseAI neural network applied to the Smartwatch ECG data compared to physicians' measure of the QTc interval from the 12-lead ECG.

Trial Locations

Locations (1)

Beacon Hospital Research Institute

🇮🇪

Dublin, Ireland

© Copyright 2025. All Rights Reserved by MedPath